Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

The state of OA: a large-scale analysis of the prevalence and impact of Open Access articles.

Piwowar H, Priem J, Larivière V, Alperin JP, Matthias L, Norlander B, Farley A, West J, Haustein S.

PeerJ. 2018 Feb 13;6:e4375. doi: 10.7717/peerj.4375. eCollection 2018.

2.

A multi-disciplinary perspective on emergent and future innovations in peer review.

Tennant JP, Dugan JM, Graziotin D, Jacques DC, Waldner F, Mietchen D, Elkhatib Y, B Collister L, Pikas CK, Crick T, Masuzzo P, Caravaggi A, Berg DR, Niemeyer KE, Ross-Hellauer T, Mannheimer S, Rigling L, Katz DS, Greshake Tzovaras B, Pacheco-Mendoza J, Fatima N, Poblet M, Isaakidis M, Irawan DE, Renaut S, Madan CR, Matthias L, Nørgaard Kjær J, O'Donnell DP, Neylon C, Kearns S, Selvaraju M, Colomb J.

Version 3. F1000Res. 2017 Jul 20 [revised 2017 Jan 1];6:1151. doi: 10.12688/f1000research.12037.3. eCollection 2017. Review.

3.

Reduced monomeric CD4 is the preferred receptor for HIV.

Matthias LJ, Azimi I, Tabrett CA, Hogg PJ.

J Biol Chem. 2010 Dec 24;285(52):40793-9. doi: 10.1074/jbc.M110.190579. Epub 2010 Oct 25.

4.

Disulfide bond that constrains the HIV-1 gp120 V3 domain is cleaved by thioredoxin.

Azimi I, Matthias LJ, Center RJ, Wong JW, Hogg PJ.

J Biol Chem. 2010 Dec 17;285(51):40072-80. doi: 10.1074/jbc.M110.185371. Epub 2010 Oct 13.

5.

Disulfide exchange in CD4.

Matthias LJ, Yam PT, Jiang XM, Hogg PJ.

Biofactors. 2003;17(1-4):241-8. Review. No abstract available.

PMID:
12897445
6.

Redox control on the cell surface: implications for HIV-1 entry.

Matthias LJ, Hogg PJ.

Antioxid Redox Signal. 2003 Feb;5(1):133-8. Review.

PMID:
12626125
7.

Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1.

Matthias LJ, Yam PT, Jiang XM, Vandegraaff N, Li P, Poumbourios P, Donoghue N, Hogg PJ.

Nat Immunol. 2002 Aug;3(8):727-32. Epub 2002 Jul 1.

PMID:
12089508

Supplemental Content

Loading ...
Support Center